Anticoagulation in large-volume leukapheresis: comparison between citrate- versus heparin-based anticoagulation on safety and CD34 ⁺ cell collection efficiency

References

• Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, . Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113:3604–11.
   PubMed Web of Science ®Google Scholar
• Reik RA, Noto TA, Fernandez HF. Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells. J Clin Apheresis. 1997;12:10–13.
   PubMedGoogle Scholar
• Buchta C, Macher M, Bieglmayer C, Höcker P, Dettke M. Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium-gluconate. Transfusion. 2003;43:1615–21.
   PubMedGoogle Scholar
• Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ, . Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood. 2008;112:2092–l100.
   PubMedGoogle Scholar
• Kishimoto M, Ohto H, Shikama Y, Kikuta A, Kimijima I, Takenoshita S. Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting. Transfusion. 2002;42:1340–7.
   PubMedGoogle Scholar
• Gašová Z, Bhuiyan-Ludvíková Z, Böhmová M, Marinov I, Vacková B, Pohlreich D, Trněný M. PBPC collections: management, techniques and risks. Transfus Apher Sci. 2010;43:237–43.
   PubMedGoogle Scholar
• Netelenbos T, van den Born J, Kessler FL, Zweegman S, Merle PA, van Oostveen JW, . Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cells. Leukemia. 2003;17:175–84.
   PubMedGoogle Scholar
• Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106:1901–10.
   PubMed Web of Science ®Google Scholar
• Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol. 2006;34:967–75.
   PubMed Web of Science ®Google Scholar
• Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, . G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3:687–l94.
   PubMed Web of Science ®Google Scholar
• Pusic I, DiPersio JF. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol. 2010;17:319–26.
   PubMed Web of Science ®Google Scholar
• Murphy JW, Cho Y, Sachpatzidis A, Fan C, Hodsdon ME, Lolis E. Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem. 2007;282:10018–27.
   PubMedGoogle Scholar
• Sadir R, Baleux F, Grosdidier A, Imberty A, Lortat-Jacob H. Characterization of the stromal cell-derived factor-1alpha-heparin complex. J Biol Chem. 2001;11:8288–96.
   Google Scholar
• Sweeney EA, Papayannopoulou T. Increase in circulating SDF-1 after treatment with sulfated glycans. The role of SDF-1 in mobilization. Ann NY Acad Sci. 2001;938:48–52.
   PubMedGoogle Scholar
• Sweeney EA, Lortat-Jacob H, Priestley GV, Nakamoto B, Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood. 2002;99:44–51.
   PubMed Web of Science ®Google Scholar
• Bolan CD, Yau YY, Cullis HC, Horwitz ME, Mackall CL, Barrett AJ, . Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens. Transfusion. 2004;44:229–38.
   PubMedGoogle Scholar
• Sevilla J, González-Vicent M, Fernández-Plaza S, Madero L, Díaz MA. Heparin based anticoagulation during peripheral blood stem cell collection may increase the CD34 + cell yield. Haematologica. 2004;89:249–51.
   PubMedGoogle Scholar
• Joint Working Party of the Transfusion and Clinical Haematology Task Forces of the British Committee for Standards in Haematology. Guidelines for the clinical use of blood cell separators. Clin Lab Haematol. 1998;20:265–78.
   PubMedGoogle Scholar
• Dettke M, Jurko S, Rüger BM, Leitner G, Greinix HT, Kalhs P, . Increase in the serum level of flt3-ligand after administration of G-CSF in healthy donors undergoing peripheral stem cell harvest. J Hematother Stem Cell Res. 2001;10:317–20.
   PubMedGoogle Scholar
• Abrahamsen JF, Stamnesfet S, Liseth K, Hervig T, Bruserud O. Large-volume leukapheresis yields more viable CD34 + cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34 + cells. Transfusion. 2005;45:248–53.
   PubMedGoogle Scholar
• Sevilla J, González-Vicent M, Lassaletta A, Ramírez M, Pérez-Martínez A, Madero L, Díaz MA. Peripheral blood progenitor cell collection adverse events for childhood allogeneic donors: variables related to the collection and safety profile. Br J Haematol. 2009;144:909–16.
   PubMedGoogle Scholar
• Bolan CD, Cecco SA, Wesley RA, Horne M, Yau YY, Remaley AT, . Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion. 2002;42:935–46.
   PubMedGoogle Scholar
• Kozuka T, Ishimaru F, Fujii K, Masuda K, Kaneda K, Imai T, . Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Bone Marrow Transplant. 2003; 31:651–4.
   PubMedGoogle Scholar
• Jin F, Zhai Q, Qiu L, Meng H, Zou D, Wang Y, . Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant. 2008;42:581–8.
   Google Scholar
• Sorensen BS, Thomsen AM, Moller BK. Collection of peripheral blood progenitor cells for autologous use: performance enhancements of COBE spectra, auto-PBSC. J Clin Apheresis. 2011; Sep 13. doi: 10.1002/jca.20308.
   PubMedGoogle Scholar
• Moller AK, Dickmeiss E, Geisler CH, Christensen LD. Recruitment of CD34 + cells during large-volume leukapheresis J Hematother Stem Cell Res. 2001;10:837–53.
   PubMedGoogle Scholar
• Torrabadella M, Olivé T, Ortega JJ, Massuet L. Enhanced HPC recruitment in children using LVL and a new automated apheresis system. Transfusion. 2000;40:404–10.
   PubMed Web of Science ®Google Scholar
• Humpe A, Riggert J, Munzel U, Köhler M. A prospective, randomized, sequential crossover trial of large-volume versus normal-volume leukapheresis procedures: effects on serum electrolytes, platelet counts, and other coagulation measures. Transfusion. 2000;40:368–74.
   PubMedGoogle Scholar
• Khanna A, Kutzmann NA. Metabolic alkalosis. J Nephrol. 2006;19(S9):S86–96.
   Google Scholar
• Nagai Y, Itabashi M, Mizutani M, Ogawa T, Yumura W, Tsuchiya K, Nitta K. A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura. Ther Apher Dial. 2008;12:86–90.
   PubMed Web of Science ®Google Scholar
• Marques MB, Huang ST. Patients with thrombotic thrombocytopenic purpura commonly develop metabolic alkalosis during therapeutic plasma exchange. J Clin Apheresis. 2001;16:120–4.
   PubMed Web of Science ®Google Scholar
• Wang S, McDonald EH, Sedor FA, Toffaletti JG. pH effects on measurements of ionized calcium and ionized magnesium in blood. Arch Pathol Lab Med. 2002;126:947–50.
   PubMed Web of Science ®Google Scholar
• Lassila R, Antovic JP, Armstrong E, Baghaei F, Dalsgaard-Nielsen J, Hillarp A, . Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia. Semin Thromb Hemost. 2011;37:328–36.
   PubMedGoogle Scholar